P598: EBI3/IL-27 DEPLETED MICROENVIRONMENT FAVOURS TUMOUR PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKAEMIA

P598: EBI3/IL-27 DEPLETED MICROENVIRONMENT FAVOURS TUMOUR PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKAEMIA

Bibliographic Details
Main Authors:	I. C. Botana, G. Pagano, W. Marina, P. M. Roessner, B. Qu, A. Ramsay, B. Stamatopoulos, M. Seiffert, J. Paggetti, E. Moussay
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000845280.88682.06

Similar Items

Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
by: Iria Fernandez Botana, et al.
Published: (2023-12-01)

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence
by: Q. Heydt, et al.
Published: (2021-09-01)

S138: MICROENVIRONMENT-REGULATED TRANSCRIPTIONS FACTORS AHR AND HIF-1Α EXPRESSION IN TREGS PROMOTE CLL PROGRESSION BY IMPAIRING CD8+ T-CELL MEDIATED ANTI-TUMOR IMMUNITY
by: G. Pagano, et al.
Published: (2022-06-01)

Method for the Analysis of the Tumor Microenvironment by Mass Cytometry: Application to Chronic Lymphocytic Leukemia
by: Susanne Gonder, et al.
Published: (2020-10-01)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
by: Martina Seiffert, et al.
Published: (2022-02-01)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Prognostic and Predictive Biomarkers and Therapy
by: Etienne Moussay, et al.
Published: (2022-01-01)

The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
by: Susanne Gonder, et al.
Published: (2021-09-01)

P598: DISRUPTION IN ONE-CARBON METABOLISM THROUGH MTHFD1 INHIBITION AS NOVEL THERAPEUTIC STRATEGY IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Elodie Viry, et al.
Published: (2023-08-01)

Natural killer cells and bone marrow mesenchymal stem cells: A dangerous liaison in multiple myeloma
by: Iria Fernandez Botana, et al.
Published: (2022-09-01)

Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends
by: Ernesto Gargiulo, et al.
Published: (2019-05-01)

Favourable prognostic factors in therapy related acute myeloid leukaemia
by: Antonijević Nebojša, et al.
Published: (2011-01-01)

High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia
by: Marina Wierz, et al.
Published: (2018-08-01)

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics
by: Moorman, A, et al.
Published: (2012)

Cloning and Expression of EBI3 and p28 Subunits of Human Interleukin 27 in E. coli
by: Ameneh Koochaki, et al.
Published: (2015-07-01)

Evidence-Based Intervention (EBI) Mapping: a systematic approach to understanding the components and logic of EBIs
by: Timothy J. Walker, et al.
Published: (2022-07-01)

Canine transmissible venereal tumour established in immunodeficient mice reprograms the gene expression profiles associated with a favourable tumour microenvironment to enable cancer malignancy
by: Chiao-Hsu Ke, et al.
Published: (2022-01-01)

Therapeutic Targeting of the Leukaemia Microenvironment
by: Vincent Kuek, et al.
Published: (2021-06-01)

Biological Data Resources at the EMBL-EBI
by: Rodrigo Lopez
Published: (2008-07-01)

Biological Data Resources at the EMBL-EBI
by: Rodrigo Lopez
Published: (2009-01-01)

The B-side of Cancer Immunity: The Underrated Tune
by: Anne Largeot, et al.
Published: (2019-05-01)

Mervân B. Ebî Hafsa Ve Methiyeleri
by: Cüneyt Maral
Published: (2021-12-01)

ChEBI: a chemistry ontology and database
by: de Matos Paula, et al.
Published: (2010-05-01)

S137: SMALL EXTRACELLULAR VESICLES IN THE LEUKEMIA MICROENVIRONMENT SUSTAIN CLL PROGRESSION BY HAMPERING T CELL-MEDIATED ANTI-TUMOR IMMUNITY
by: E. Gargiulo, et al.
Published: (2022-06-01)

Organic waste management for EBI in Quebec, feedstock analysis
by: Sylvestre, Olivier, M. Eng. Massachusetts Institute of Technology
Published: (2014)

Variants of Čebyšev's inequality with applications
by: Pečarić J, et al.
Published: (2006-01-01)

The EBiSC iPSC bank for disease studies
by: Rachel Steeg, et al.
Published: (2020-12-01)

m6A RNA methylation regulators predict prognosis and indicate characteristics of tumour microenvironment infiltration in acute myeloid leukaemia
by: Xinai Liao, et al.
Published: (2023-12-01)

Extramedullary Myeloid Cell Tumour Presenting As Leukaemia Cutis
by: Thappa Devinder Mohan, et al.
Published: (2002-01-01)

Chronic lymphocytic leukaemia: An immunobiology approach
by: Kostareli Efterpi, et al.
Published: (2008-01-01)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
by: Pedro Marques, et al.
Published: (2019-11-01)

Is it functional? Report on the first BSPR/EBI meeting on functional proteomics.
by: Pixton, K
Published: (2004)

Making bioinformatics training FAIR: the EMBL-EBI training portal
by: A. L. Swan, et al.
Published: (2024-01-01)

Cultural adaptations and cultural factors in EBI implementation with Latinx communities
by: Felipe González Castro, et al.
Published: (2023-03-01)

Life cycle analysis of waste management options for EBI in Quebec
by: Wilson, Jaclyn D
Published: (2014)

Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality
by: Anna Rychter, et al.
Published: (2023-01-01)

The Role of CDK5 in Tumours and Tumour Microenvironments
by: Phuong Anh Do, et al.
Published: (2020-12-01)

Exploring tumour suppressor ATRX and telomere maintenance in MLLr leukaemia
by: Gracias, D
Published: (2018)

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia
by: Vanessa Klapp, et al.
Published: (2023-12-01)

Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo
by: Ernesto Gargiulo, et al.
Published: (2022-12-01)

The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity
by: Joanna eBaginska, et al.
Published: (2013-12-01)